Defense Health Agency

Stories

UCSF gets federal funding for long COVID clinical trial network

As of September 2026: Funding source for the PROBE-PASC award

The Defense Health Agency has committed $7.1 million to UC San Francisco for a clinical trial network studying the biological mechanisms of long COVID. The award, recorded Aug. 18, covers work starting Sept. 1 under the PROBE-PASC project.

Updated Sep 2

FDA licenses first US freeze-dried plasma product

New Capabilities

As of September 2026: Co-developed Ezplaz through its WPAC program

For decades, US plasma transfusions required a freezer and time to thaw. Ezplaz, the first US-licensed freeze-dried plasma, reconstitutes in about 2.5 minutes and sits on a shelf for a year.

Updated Sep 1